Nasdaq:US$20.17 (-0.79) | HKEX:HK$32.00 (+0.30) | AIM:£3.23 (-0.01)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2007-06-18

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility